Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.
Status:
Unknown status
Trial end date:
2020-01-30
Target enrollment:
Participant gender:
Summary
End-stage chronic kidney disease is associated with the condition of chronic inflammation.
Patients on hemodialysis are known to be predisposed to several factors that predispose to
inflammation: dialysis membranes, central venous catheters, oxidative stress, fluid overload,
sodium overload, uraemic toxins. Propolis, a natural resin produced by bees from plant
materials, has anti-inflammatory, immunomodulatory, and anti-oxidant properties. The aim of
this study was to evaluate the impact of Brazilian green propolis extract on inflammation in
hemodialysis patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborators:
Alagoas State University of Health Science , Maceió , Brazil. Hospital Sao Rafael